InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Thompson Elizabeth H.Z., Directeur de la Recherche et Développement. Director active across 1 companies, notably Horizon Therapeutics Public Ltd Co. Cumulatively, 7 reports have been published. Total volume traded: €2.2m. The latest transaction was filed on 18 April 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€868,5518,098 shares@ €107.254939.1% of flow
Ordinary Shares
SEC:0001209191-22-024924:0·
13,999 shares
Ordinary Shares
SEC:0001209191-22-002295·
13,999 shares
Ordinary Shares
SEC:0001209191-22-002295:0·
€677,6317,542 shares@ €89.8476100.0% of flow
Ordinary Shares
SEC:0001209191-21-050212·
€677,6317,542 shares@ €89.847630.5% of flow
Ordinary Shares
SEC:0001209191-21-050212:0·
12,077 shares
Ordinary Shares
SEC:0001209191-21-045062·
12,077 shares
Ordinary Shares
SEC:0001209191-21-045062:0·
7 of 7 declarations
About Thompson Elizabeth H.Z.
Elizabeth H.Z. Thompson is the Executive Vice President of Research & Development at Horizon Therapeutics Public Ltd Co. She oversees the company's research and development initiatives. Her expertise is essential in ensuring innovation and safety in the treatments offered.
